Chlorogenic acid attenuates cyclophosphamide-induced rat interstitial cystitis

Area of Science:

• Pharmacology
• Urology
• Molecular Biology

Background:

• Interstitial cystitis (IC) is a chronic bladder condition causing pain and urinary urgency.
• Cyclophosphamide (CYP) is a chemotherapeutic agent that can induce IC-like symptoms in animal models.
• Chlorogenic acid (CGA) is a natural compound with potential anti-inflammatory and antioxidant properties.

Purpose of the Study:

• To investigate the therapeutic effects of CGA on CYP-induced IC in rats.
• To elucidate the molecular mechanisms underlying CGA's action in IC.

Main Methods:

• An IC rat model was established using CYP injection.
• Rats were divided into control and CGA-treated groups.
• Urodynamic parameters, apoptosis-related proteins (Caspase3, Bax, Bcl-2), inflammatory biomarkers, and MAPK/NF-κB pathway activation were analyzed.

Main Results:

• CGA treatment significantly improved bladder function in IC rats.
• CGA reduced bladder inflammation and apoptosis by modulating protein expression.
• CGA inhibited CYP-induced MAPK/NF-κB phosphorylation.

Conclusions:

• CGA demonstrates therapeutic potential for IC by reducing inflammation and apoptosis.
• The MAPK/NF-κB pathway is likely involved in the protective effects of CGA against IC.
• CGA may offer a novel therapeutic strategy for managing IC.